Skip to content
DraconiticResearch
Search Sources API
186,541 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NC-NDOpen forum infectious diseases

Sexually Transmitted Infections Among Men Who Have Sex With Men Using Daily and Event-Driven HIV Pre-Exposure Prophylaxis: A Retrospective Cohort Study.

  1. 1Melbourne Sexual Health Centre, Bayside Health, Melbourne, Victoria, Australia.
  2. 2School of Translational Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  3. 3Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Abstract

Background

HIV pre-exposure prophylaxis (PrEP) has reduced HIV incidence among men who have sex with men (MSM), but bacterial sexually transmitted infections (STIs) remain common, with limited data comparing regimens.Methods

A retrospective cohort study was conducted at Melbourne Sexual Health Centre, Australia (2024-2025). MSM aged ≥18 reporting PrEP use (daily, event-driven, or switching) who were tested for chlamydia, gonorrhea, or syphilis were included. Positivity was assessed at first consultation (baseline); incidence was assessed among those with ≥2 tests ≥30 days apart. Logistic and Poisson regression estimated associations and incidence rate ratios.Results

Among 3229 PrEP users (median age 33, IQR 29-39), 51.0% were daily, 43.2% event-driven, and 5.8% switchers. At baseline, 33.7% (765/2268) had any STI, with lower positivity among event-driven users (29.8%) than daily users (37.0%) or switchers (37.6%; P = .001), primarily driven by differences in gonorrhea positivity. After adjustment, event-driven PrEP use was independently associated with lower odds of baseline STI positivity (aOR 0.75, 95% CI 0.62-0.90), while Medicare ineligibility and recent partners had higher odds. Over 700.6 person-years, any-STI incidence (39.4/100 person-years) did not differ across regimens.Conclusions

Although event-driven users had lower baseline STI positivity, incidence was similar across regimens, suggesting baseline differences reflect underlying risk profiles rather than ongoing risk.

Related

  1. Prevalence of sexually transmitted infections among pregnant migrant and refugee women: Protocol for a systematic review and meta-analysis
    Darío S. López-Delgado, Carlos A. Narváez, Gloria L. Chapués-Andrade +8
    PLOS OnePeer-reviewedCC BY 4.0Full textStatisticsInfectious diseasePLOS
  2. Sexually Transmitted Infections in the Third Age: Rising Risk Among over 65-Year-Old Persons in Southern Sardinia
    Grazia Vivanet, Federica Perra, Caterina Ferreli +1
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  3. Sexual behavior-related exposures, sexually transmitted infections, and viral markers in relation to prostate cancer risk: a systematic review and meta-analysis
    Po Liang, Hong Gu, Jia Liu +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC
  4. Client, health care provider, and policymaker perspectives on point-of-care/near-point-of-care testing for sexually transmitted infections in community pharmacies in Uganda
    Annet A Onzia, Adelline Twimukye, Johan H Melendez +5
    PLOS OnePeer-reviewedCC BYFull textMicrobiologyPharmacology & toxicologyPLOSEurope PMC
  5. Serological Markers of Selected Sexually Transmitted Infections (HBV, HCV, HIV, and Syphilis) in Patients with Anogenital Warts: A Two-Centre, Five-Year Study.
    Aziz Alper Biten, Meryem Çetin, Simge Süel Eroğlu +3
    Pathogens (Basel, Switzerland)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{wijekoon2026sexually,
  title = {{Sexually Transmitted Infections Among Men Who Have Sex With Men Using Daily and Event-Driven HIV Pre-Exposure Prophylaxis: A Retrospective Cohort Study.}},
  author = {Danushi Wijekoon and Ei T Aung and Phyu Mon Latt and Andrew Buchanan and Nyi Nyi Soe and Eric P F Chow},
  journal = {Open forum infectious diseases},
  year = {2026},
  month = oct,
  doi = {10.1093/ofid/ofag643},
  url = {https://europepmc.org/article/MED/42909880},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Sexually Transmitted Infections Among Men Who Have Sex With Men Using Daily and Event-Driven HIV Pre-Exposure Prophylaxis: A Retrospective Cohort Study.
AU  - Danushi Wijekoon
AU  - Ei T Aung
AU  - Phyu Mon Latt
AU  - Andrew Buchanan
AU  - Nyi Nyi Soe
AU  - Eric P F Chow
PY  - 2026
DA  - 2026/10/05
JO  - Open forum infectious diseases
DO  - 10.1093/ofid/ofag643
UR  - https://europepmc.org/article/MED/42909880
AB  - Background  HIV pre-exposure prophylaxis (PrEP) has reduced HIV incidence among men who have sex with men (MSM), but bacterial sexually transmitted infections (STIs) remain common, with limited data comparing regimens.Methods  A retrospective cohort study was conducted at Melbourne Sexual Health Centre, Australia (2024-2025). MSM aged ≥18 reporting PrEP use (daily, event-driven, or switching) who were tested for chlamydia, gonorrhea, or syphilis were included. Positivity was assessed at first consultation (baseline); incidence was assessed among those with ≥2 tests ≥30 days apart. Logistic and Poisson regression estimated associations and incidence rate ratios.Results  Among 3229 PrEP users (median age 33, IQR 29-39), 51.0% were daily, 43.2% event-driven, and 5.8% switchers. At baseline, 33.7% (765/2268) had any STI, with lower positivity among event-driven users (29.8%) than daily users (37.0%) or switchers (37.6%; P = .001), primarily driven by differences in gonorrhea positivity. After adjustment, event-driven PrEP use was independently associated with lower odds of baseline STI positivity (aOR 0.75, 95% CI 0.62-0.90), while Medicare ineligibility and recent partners had higher odds. Over 700.6 person-years, any-STI incidence (39.4/100 person-years) did not differ across regimens.Conclusions  Although event-driven users had lower baseline STI positivity, incidence was similar across regimens, suggesting baseline differences reflect underlying risk profiles rather than ongoing risk.
SN  - 2328-8957
ER  -